Screening compound: InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3

Screening compound: InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3
Screening compound: InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P970-1111

Molecular Formula

C16H20N2O2 (C16 H20 N2 O2)

Compound Name

4-cyano-N-methyl-N-[(4-methyloxan-4-yl)methyl]benzamide

IUPAC name

4-cyano-N-methyl-N-[(4-methyloxan-4-yl)methyl]benzamide

SMILES

CC1(CN(C)C(c(cc2)ccc2C#N)=O)CCOCC1

InChI

InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3

InChI Key

BZXFECRYNUCDRP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD30462239

InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3 in Drug Discovery

Included in Screening Libraries

3D-Fragment Library (4274 compounds)

Bcl2-PPI Inhibitors Library (12246 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Fragments
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3?
Check Price and Availability of InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C16H20N2O2/c1-16(7-9-20-10-8-16)12-18(2)15(19)14-5-3-13(11-17)4-6-14/h3-6H,7-10,12H2,1-2H3 available by request